
zzso zzso zzso is an important risk factor for zzso According to a pooled analysis of controlled clinical trials with zzso zzso therapy reduces stroke risk by zzso However, clinicians must decide whether the benefit of long-term zzso therapy with available agents outweighs the risk of bleeding for individual zzso zzso issued by the American College of zzso Physicians and by the joint American College of zzso American Heart Association, and the European Society of zzso task force recommend zzso therapy to protect zzso patients from stroke based on zzso zzso zzso factors for stroke zzso patients include age zzso or zzso years; zzso zzso zzso cardiovascular zzso zzso heart zzso and history of stroke, transient zzso attack, or zzso Patients at high risk for stroke experience greater absolute benefit from zzso therapy than patients at low zzso The guidelines are consistent in recommendations for high-risk patients zzso therapy, international zzso ratio zzso to zzso and low-risk patients zzso 325 zzso but differ for zzso patients with diabetes or heart zzso The guidelines continue to evolve, and future guidelines are likely to incorporate new clinical data, including the zzso zzso for determining risk and the results of the zzso zzso zzso Investigation of Rhythm Management trial, the Rate Control versus zzso zzso for zzso zzso zzso study, and the Stroke Prevention Using an zzso zzso zzso in zzso zzso II to V zzso 

